Represented Grupo Landsteiner Scientific in the issuance of preferred shares and the initial suscription and equity investment by Poseidon Asset Management.

Poseidon Asset Management is one of the longest running dedicated cannabis investment funds, including investments in pharmaceutical companies that are involved in the research and development of medical cannabis products.